Pneumococcal vaccine indications

Risk factors indicating the need for pneumococcal vaccination in people 19 to 64 years of age
[checklist value="alcoholism|chronic heart disease|chronic lung disease|chronic liver disease|chronic renal failure|cigarette smoking|cochlear implant|congenital or acquired asplenia|cerebrospinal fluid leak|diabetes mellitus|generalized malignancy|HIV|Hodgkin disease|immunodeficiency|iatrogenic immunosuppression|leukemia|lymphoma|multiple myeloma|nephrotic syndrome|solid organ transplant| sickle cell disease|hemoglobinopathy"]
[checkbox memo="Hide/Display References" name="footnotes" value=""][conditional field="footnotes" condition="(footnotes).isNot('')"]
references: 
 [link url="https://www.cdc.gov/mmwr/volumes/71/wr/mm7104a1.htm" memo="#1"] Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:109–117.[/conditional]